Ignite Creation Date:
2024-05-06 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 1:53 PM
Study NCT ID:
NCT04697446
Status:
UNKNOWN
Last Update Posted:
2021-08-10
First Post:
2020-12-16
Brief Title:
External Control Observational Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Sponsor:
Organization:
Blueprint Medicines Corporation